Onconic Therapeutics Inc. (KOSDAQ:476060)
23,500
+450 (1.95%)
At close: Feb 27, 2026
542.95% (1Y)
| Market Cap | 1.05T +584.7% |
| Revenue (ttm) | 46.65B +529.9% |
| Net Income | 16.75B |
| EPS | 1,513.84 |
| Shares Out | 44.89M |
| PE Ratio | 15.52 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,086,104 |
| Average Volume | 1,618,934 |
| Open | 23,850 |
| Previous Close | 23,050 |
| Day's Range | 22,700 - 24,450 |
| 52-Week Range | 3,138 - 28,900 |
| Beta | n/a |
| RSI | 62.24 |
| Earnings Date | Mar 13, 2026 |